124 Yagui M, Perales MT, Asencios L, et al. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis 2006. 10(8): p. 838-43.

125 Petti, CA, Polage CR, Quinn TC, et al. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 2006; 42(3): 377-82.

126 Blaya JA and HS Fraser. Development, implementation and preliminary study of a PDA-based tuberculosis result collection system. AMIA Annu Symp Proc 2006: 41-5.

127 Blaya, JA, Shin SS, Yagui MJ, et al. A web-based laboratory information system to improve quality of care of tuberculosis patients in Peru: functional requirements, implementation and usage statistics. BMC Med Inform Decis Mak 2007; 7: 33.

128 Global Tuberculosis Control 2007. Surveillance, Planning, Financing. World Health Organization: Geneva, 2007.

129 Rojpibulstit M, Kanjanakiritamrong J and V Chongsuvivatwong. Patient and health system delays in the diagnosis of tuberculosis in Southern Thailand after health care reform. Int J Tuberc Lung Dis 2006; 10(4):422-428.

130 Lonnroth K, Thuong LM, Linh PD and VK Diwan. Delay and discontinuity—a survey of TB patients’ search of a diagnosis in a diversified health care system. Int J Tuberc Lung Dis 1999; 3:992-1000.

131 Liam CK and BG Tang. Delay in the diagnosis and treatment of pulmonary tuberculosis in patients attending a university teaching hospital. Int J Tuberc Lung Dis 1997; 1:326-332.

132 Rajeswari R, Chandrasekaran V, Suhadev M, Sivasubramaniam S, Sudha G and G Renu. Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. Int J Tuberc Lung Dis 2002; 6:789-795.

133 Cheng G, Tolhurst R, Li RZ, et al. Factors affecting delays in tuberculosis diagnosis in rural China: a case study in four counties in Shandong Province. Trop Med Int health 2005; 99:355-362.

134 Lorent N, Mugwaneza P, Mugabekazi J, Gasana M, Van Bastelaere S, Clerinx J, et al. Risk factors for delay in the diagnosis and treatment of tuberculosis at a referral hospital in Rwanda. Int J Tuberc Lung Dis 2008; 12(4):392-396.

135 World Health Organization/International Union Against Tuberculosis and Lung Disease. Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: report no. 4. Geneva, Switzerland: World Health Organization; 2008. Pg 14

136 Summary: Strategic Plans 2006 - 2015 of the Partnership, Working Group and Secretariat (Stop TB) http://www.stoptb.org/globalplan/plan_p3main.asp?p=3

137 The Global MDR-TB & XDR-TB Response Plan 2007-2008. In. Geneva: Stop TB Partnership; 2007. www.stoptb.org/resource_center/assets/documents/Global%20MDR-TB_and_%20XDR-TB_Response%20Plan_2007-08.pdf

138 Mattelli, Migliori, Cirillo, Centis, Girardi, Raviglioni Multi-drug Resistant and Extensively-drug Resistant Mycobacterium Tuberculosis: Epidemiology and Control. Future Drugs, 2007. Pg 865

139 World Health Organization, “Stop TB Partnership delivers treatments for 10 million people in six years” http://www.who.int/mediacentre/news/releases/2007/pr25/en/index.html

140 Interview with GDF, November 2007

141 Request for Proposals for second-line anti-TB Drugs Procurement Agent(s), August, 2006 Available: http://www.stoptb.org/gdf/newsevents/newsarchive.asp

142 Unitaid Homepage http://www.unitaid.eu

143 Unitaid Homepage http://www.unitaid.eu

144 Interviews with GLC representatives



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement